Goodpath
goodpath.com
Actively hiring
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$18M
1 round on record
Latest round
$18M
Series A · Sep 2025 · 12 mo ago
Backers
1
Healthy Ventures
The money's age
Due for its next round
12 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 13, 2025
Raised a round Series A $18M · led by MassMutual Ventures · Pulse 2.0
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series A | Sep 2025 | $18M | MassMutual Ventures lead, Healthy Ventures | Pulse 2.0 |
Backed byfrom the funds' portfolios and accelerator catalogs
Healthy Ventures Similar startupsby what they do, their industry and backers
Reema Health provides integrated behavioral health services combined with social needs navigation to deliver comprehensive whole-person…
L is B （エルイズビー）は、ビジネスチャット「direct」や、現場の写真管理システム「タグショット/タグアルバム」、現場のノウハウを動画で共有する「ナレッジ動画」など多彩なソリューションを提供し、お客様の課題解決に向け、現場の業務改善・DX化を支援します。.
Kailera is a late clinical-stage biotechnology company advancing a diversified pipeline of GLP-1 therapies to provide options for people…
Upward Health is an in-home, multidisciplinary medical group providing 24/7 whole-person care https://youtu.be/TUmpsus-_aA Our clinical…
Whole-person online opioid, alcohol, and SUD addiction treatment grounded in unconditional support. A dedicated care team with Drs, Peer…
Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related…
Overview
Goodpath delivers whole-person, integrative care for obesity and cardiometabolic conditions, with direct-to-employer GLP-1 access through WeightRx.
News
Goodpath Expands Weight Management to Help Employers Regain Control of GLP-1 Cost, Access, and Clinical Oversight
Goodpath, the virtual integrative care provider for chronic conditions, today announced the expansion of its Weight Management program, adding GLP-1 access and pricing options that sit outside the traditional pharmacy benefit. Building on its existing mul
Read more
Report
Goodpath Expands Direct-to-Employer and Self-Pay Access to Wegovy Through Novo Nordisk Collaboration
Goodpath, the virtual integrative care provider for chronic conditions, today announced direct-to-employer (DTE) and self-pay access to Wegovy, including both injectable and newly-approved oral formulations, through a collaboration with Novo Nordisk. This
Read more
Report
Goodpath Expands Direct-to-Employer and Self-Pay Access to Wegovy Through Novo Nordisk Collaboration
Read more
Report
Goodpath: $18 Million Series A Closed To Expand AI-Based Chronic Care Platform
Goodpath has secured $18 million in Series A financing led by MassMutual Ventures, with additional participation from Healthy Ventures and existing backers. The new funding will be used to accelerate the rollout of its AI-driven, evidence-based care model
Read more
Report
Goodpath Rakes In $18M for Chronic Condition Platform
Goodpath's Series A round was led by MassMutual Ventures and included participation from Healthy Ventures. In total, the company has raised $22 million.
Read more
Report
Goodpath Adds Self-Pay GLP-1 Option Through Integration with LillyDirect Pharmacy Provider GiftHealth
/PRNewswire/ -- Goodpath, the leading virtual provider of whole-person care for chronic conditions, today announced a pharmacy integration agreement with...
Read more
Report
Goodpath, Provider of Virtual Whole-Person Care, Begins Delivering Cancer Survivorship Program
Read more
Report
Goodpath and long COVID recovery through integrative care
Dr. Akl Fahed, chief medical adviser at Goodpath, explains how their virtual integrative care model can treat long COVID.
Read more
Report
Financials
Total raised
$18M
Latest round
Series A
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series A | 2025 | $18M | Details |